Literature DB >> 29396651

[Primary treatment of anal cancer].

H Dralle1, K Kols2, H Witzigmann3, R Viebahn4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29396651     DOI： 10.1007/s00104-017-0573-2

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


× No keyword cloud information.
  10 in total

1.  Anal cancer - a review.

Authors:  Sajad Ahmad Salati; Azzam Al Kadi
Journal:  Int J Health Sci (Qassim)       Date:  2012-06

2.  Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  R Glynne-Jones; P J Nilsson; C Aschele; V Goh; D Peiffert; A Cervantes; D Arnold
Journal:  Ann Oncol       Date:  2014-07-06       Impact factor: 32.976

3.  Combined therapy for cancer of the anal canal: a preliminary report.

Authors:  N D Nigro; V K Vaitkevicius; B Considine
Journal:  Dis Colon Rectum       Date:  1974 May-Jun       Impact factor: 4.585

4.  Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial.

Authors:  Didier Peiffert; Laetitia Tournier-Rangeard; Jean-Pierre Gérard; Claire Lemanski; Eric François; Marc Giovannini; Frédérique Cvitkovic; Xavier Mirabel; Olivier Bouché; Elisabeth Luporsi; Thierry Conroy; Christine Montoto-Grillot; Françoise Mornex; Antoine Lusinchi; Jean-Michel Hannoun-Lévi; Jean-François Seitz; Antoine Adenis; Christophe Hennequin; Bernard Denis; Michel Ducreux
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

5.  Outcome of salvage surgery for anal squamous cell carcinoma.

Authors:  D A Harris; J Williamson; M Davies; M D Evans; P Drew; J Beynon
Journal:  Colorectal Dis       Date:  2013-08       Impact factor: 3.788

6.  Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.

Authors:  Jaffer A Ajani; Kathryn A Winter; Leonard L Gunderson; John Pedersen; Al B Benson; Charles R Thomas; Robert J Mayer; Michael G Haddock; Tyvin A Rich; Christopher Willett
Journal:  JAMA       Date:  2008-04-23       Impact factor: 56.272

7.  Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging.

Authors:  S D Otto; L Lee; H J Buhr; B Frericks; S Höcht; A J Kroesen
Journal:  J Gastrointest Surg       Date:  2009-04-14       Impact factor: 3.452

8.  Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.

Authors:  Roger D James; Robert Glynne-Jones; Helen M Meadows; David Cunningham; Arthur Sun Myint; Mark P Saunders; Timothy Maughan; Alec McDonald; Sharadah Essapen; Martin Leslie; Stephen Falk; Charles Wilson; Simon Gollins; Rubina Begum; Jonathan Ledermann; Latha Kadalayil; David Sebag-Montefiore
Journal:  Lancet Oncol       Date:  2013-04-09       Impact factor: 41.316

Review 9.  Anal neoplasms.

Authors:  Kelly Garrett; Matthew F Kalady
Journal:  Surg Clin North Am       Date:  2010-02       Impact factor: 2.741

Review 10.  Background and Current Treatment of Squamous Cell Carcinoma of the Anus.

Authors:  Rob Glynne-Jones; Waqar Saleem; Mark Harrison; Suzy Mawdsley; Marcia Hall
Journal:  Oncol Ther       Date:  2016-08-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.